(Q38466875)

3 September 2017

title

Expression of Bcl-2 and Bax in oligodendrogliomas and their relationship to apoptosis (English)

1 reference

3 September 2017

1 reference

Delgado MB

1

1 reference

3 September 2017

Anderson JR

series ordinal

2

1 reference

3 September 2017

Whittle IR

series ordinal

3

1 reference

3 September 2017

Wharton SB

series ordinal

4

1 reference

3 September 2017

publication date

1 October 1999

1 reference

Neuropathology and Applied Neurobiology

3 September 2017

published in

1 reference

3 September 2017

volume

25

1 reference

3 September 2017

issue

5

1 reference

3 September 2017

page(s)

400-407

1 reference

p53 in signaling checkpoint arrest or apoptosis

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Clinicopathologic correlations in the oligodendroglioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Successful chemotherapy for recurrent malignant oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

New members of the Bcl-2 family and their protein partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

p53 and brain tumors: from gene mutations to gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Mutation of the p53 gene in human astrocytic tumours correlates with increased resistance to DNA-damaging agents but not to anti-microtubule anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Proteolytic cleavage during chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

The proto-oncogene Bcl-2 and its role in regulating apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Apoptosis and cell proliferation in human neuroepithelial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Role of apoptosis in the prognosis of oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

21 January 2018

Apoptosis and therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Tyramine amplification technique in routine immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Programmed cell death: apoptosis and oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Apoptosis in human primary brain tumours: actions of arachidonic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Oligodendroglioma: an analysis of 42 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Bax suppresses tumorigenesis and stimulates apoptosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.1999.00199.X

10.1046/J.1365-2990.1999.00199.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference